Status:
NOT_YET_RECRUITING
Bleeding in Multiple Myeloma
Lead Sponsor:
University Medical Center Groningen
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
* Background Multiple myeloma (MM) is a haematological malignancy characterised by uncontrolled plasma cell proliferation leading to bone damage, anaemia, kidney failure, and hypercalcemia. Venous thr...
Eligibility Criteria
Inclusion
- Patients must be newly diagnosed with MM.
- MM patients must be receiving thromboprophylaxis (aspirin or LMWH).
- Patient must be willing or able to fill-in questionnaires.
Exclusion
- Patients objecting to the use of their data for research purposes.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06482931
Start Date
October 1 2024
End Date
December 31 2027
Last Update
July 1 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.